IOVS Health Education Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohguro, H.
Right arrow Articles by Maruyama, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohguro, H.
Right arrow Articles by Maruyama, I.
(Investigative Ophthalmology and Visual Science. 1999;40:3160-3167.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Cancer-Associated Retinopathy Induced by Both Anti-Recoverin and Anti-hsc70 Antibodies In Vivo

Hiroshi Ohguro, Kei–ichi Ogawa, Tadao Maeda, Akiko Maeda and Ikuyo Maruyama

From the Department of Ophthalmology, Sapporo Medical University School of Medicine, Sapporo, Japan.

PURPOSE. In a previous study, both recoverin and heat shock cognate protein 70 (hsc 70) were found as autoantigens recognized by sera from four patients with cancer-associated retinopathy (CAR). This observation suggested that autoimmune reactions against recoverin and hsc 70 might be involved together in the pathogenesis of CAR. The purpose of the present study is to investigate the effects of these autoantibodies on retinas in vivo.

METHODS. Functional and morphologic properties of the retinas were evaluated after anti-recoverin and/or anti-hsc 70 antibodies were intravitreously injected into Lewis rats’ eyes.

RESULTS. Responses in electroretinogram (ERG) of eyes penetrated with anti-hsc 70 antibody were comparable with the control, but those with anti-recoverin antibody were remarkably reduced during the 3-week period after the injection. Such anti-recoverin antibody–induced reduction was significantly enhanced by copenetration with anti-hsc 70 antibody. Immunofluorescence microscopy demonstrated that after intravitreal injection, anti-recoverin antibody penetrated toward the outer nuclear layer (ONL) and outer segments within 12 to 24 hours, and the presence of the antibody in the retina diminished during the next few days. Histopathology revealed significant thinning of the ONL and inner nuclear layer (INL) in the affected retina in comparison with the control. Throughout the ONL and INL, apoptotic cells were recognized by TdT-dUTP terminal nick-end labeling. The antibody-induced retinal dysfunction was effectively treated by administrations of either corticosteroid or cyclosporin A.

CONCLUSIONS. These observations suggest that anti-recoverin– and anti-hsc 70 antibody–induced retinal dysfunction in Lewis rat is a good model to study the pathophysiology of CAR.




This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
H. A. Ferreyra, T. Jayasundera, N. W. Khan, S. He, Y. Lu, and J. R. Heckenlively
Management of Autoimmune Retinopathies With Immunosuppression
Arch Ophthalmol, April 1, 2009; 127(4): 390 - 397.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
F. Ishikawa, H. Ohguro, I. Ohguro, H. Yamazaki, K. Mamiya, T. Metoki, T. Ito, Y. Yokoi, and M. Nakazawa
Prolonged Rhodopsin Phosphorylation in Light-Induced Retinal Degeneration in Rat Models
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5204 - 5211.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Shirvan, M. Kimron, V. Holdengreber, I. Ziv, Y. Ben-Shaul, S. Melamed, E. Melamed, A. Barzilai, and A. S. Solomon
Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy
J. Biol. Chem., December 13, 2002; 277(51): 49799 - 49807.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Yamazaki, H. Ohguro, T. Maeda, I. Maruyama, Y. Takano, T. Metoki, M. Nakazawa, H. Sawada, and M. Dezawa
Preservation of Retinal Morphology and Functions in Royal College Surgeons Rat by Nilvadipine, a Ca2+ Antagonist
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 919 - 926.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Ohguro, K.-i. Ogawa, T. Maeda, I. Maruyama, A. Maeda, Y. Takano, and M. Nakazawa
Retinal Dysfunction in Cancer-Associated Retinopathy Is Improved by Ca2+ Antagonist Administration and Dark Adaptation
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2589 - 2595.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Maeda, A. Maeda, I. Maruyama, K.-i. Ogawa, Y. Kuroki, H. Sahara, N. Sato, and H. Ohguro
Mechanisms of Photoreceptor Cell Death in Cancer-Associated Retinopathy
Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 705 - 712.
[Abstract] [Full Text]

Home page
 Arch OphthalmolHome page
J. R. Heckenlively, A. A. Fawzi, J. Oversier, B. L. Jordan, and N. Aptsiauri
Autoimmune Retinopathy: Patients With Antirecoverin Immunoreactivity and Panretinal Degeneration
Arch Ophthalmol, November 1, 2000; 118(11): 1525 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
G. Adamus
Antirecoverin Antibodies and Autoimmune Retinopathy
Arch Ophthalmol, November 1, 2000; 118(11): 1577 - 1578.
[Full Text] [PDF]

Home page
 IOVSHome page
I. Maruyama, H. Ohguro, and Y. Ikeda
Retinal Ganglion Cells Recognized by Serum Autoantibody against {gamma}-Enolase Found in Glaucoma Patients
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1657 - 1665.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology